PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.95
+0.15 (0.34%)
Aug 3, 2026, 4:05 PM CET
PolyPeptide Group AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 391.95 | 338.77 | 324.85 | 283.46 | 286.22 | |
Revenue Growth | 15.70% | 4.28% | 14.60% | -0.96% | 27.31% |
Cost of Revenue | 325.34 | 299.42 | 315.73 | 228.99 | 182.43 |
Gross Profit | 66.61 | 39.35 | 9.12 | 54.48 | 103.79 |
Selling, General & Admin | 55.64 | 45.62 | 44.13 | 40.63 | 38.22 |
Research & Development | 2.28 | 1.1 | 1.47 | 1.24 | 1.41 |
Total Operating Expenses | 57.92 | 46.71 | 45.59 | 41.87 | 39.63 |
Operating Income | 8.69 | -7.36 | -36.47 | 12.61 | 64.17 |
Interest Income | 1.84 | 6.8 | 0.1 | 0.01 | 0.65 |
Interest Expense | -30.59 | -17.58 | -21.88 | -5.05 | -4.97 |
Total Non-Operating Income (Expense) | -28.75 | -10.78 | -21.78 | -5.04 | -4.32 |
Pretax Income | -20.06 | -18.15 | -58.24 | 7.57 | 59.85 |
Provision for Income Taxes | 1.11 | 1.42 | -6.8 | -0.2 | 12.59 |
Net Income | -21.17 | -19.56 | -51.44 | 7.77 | 47.26 |
Net Income to Common | -21.17 | -19.56 | -51.44 | 7.77 | 47.26 |
Net Income Growth | - | - | - | -83.56% | 50.81% |
Shares Outstanding (Basic) | 33 | 33 | 33 | 33 | 32 |
Shares Outstanding (Diluted) | 33 | 33 | 33 | 33 | 32 |
Shares Change | 0.09% | 0.10% | -0.11% | 2.74% | 7.08% |
EPS (Basic) | -0.64 | -0.59 | -1.56 | 0.24 | 1.47 |
EPS (Diluted) | -0.64 | -0.59 | -1.56 | 0.24 | 1.47 |
EPS Growth | - | - | - | -83.67% | 41.35% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -30.24 | 3.65 | -16.41 | -69.64 | -16.61 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.92 | 0.11 | -0.50 | -2.11 | -0.52 |
Dividends Per Share | - | - | - | - | 0.289 |
Dividend Growth | - | - | - | - | - |
Gross Margin | 17.00% | 11.62% | 2.81% | 19.22% | 36.26% |
Operating Margin | 2.22% | -2.17% | -11.23% | 4.45% | 22.42% |
Profit Margin | -5.40% | -5.78% | -15.83% | 2.74% | 16.51% |
FCF Margin | -7.72% | 1.08% | -5.05% | -24.57% | -5.80% |
EBITDA | 46.76 | 25.35 | -6 | 38.67 | 84.85 |
EBITDA Margin | 11.93% | 7.48% | -1.85% | 13.64% | 29.64% |
EBIT | 8.69 | -7.36 | -36.47 | 12.61 | 64.17 |
EBIT Margin | 2.22% | -2.17% | -11.23% | 4.45% | 22.42% |
Effective Tax Rate | -5.54% | -7.82% | 11.68% | -2.64% | 21.04% |